
Sara Elizabeth Townsley
Examiner (ID: 5080, Phone: (571)270-7672 , Office: P/1629 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1612, 1613 |
| Total Applications | 512 |
| Issued Applications | 97 |
| Pending Applications | 84 |
| Abandoned Applications | 350 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4887590
[patent_doc_number] => 20080261922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Pharmacological Treatments for Sleep Disorders (Apnoe) With Prostanoid Receptor Antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/090131
[patent_app_country] => US
[patent_app_date] => 2006-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11514
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20080261922.pdf
[firstpage_image] =>[orig_patent_app_number] => 12090131
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/090131 | Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists | Oct 12, 2006 | Issued |
Array
(
[id] => 5079253
[patent_doc_number] => 20070122477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'Methods and articles for treating 25-hydroxyvitamin D insufficiency and deficiency'
[patent_app_type] => utility
[patent_app_number] => 11/549001
[patent_app_country] => US
[patent_app_date] => 2006-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9467
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20070122477.pdf
[firstpage_image] =>[orig_patent_app_number] => 11549001
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/549001 | Methods and articles for treating 25-hydroxyvitamin D insufficiency and deficiency | Oct 11, 2006 | Abandoned |
Array
(
[id] => 5019003
[patent_doc_number] => 20070144968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Separation of fulvestrant isomers'
[patent_app_type] => utility
[patent_app_number] => 11/544522
[patent_app_country] => US
[patent_app_date] => 2006-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4215
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20070144968.pdf
[firstpage_image] =>[orig_patent_app_number] => 11544522
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/544522 | Separation of fulvestrant isomers | Oct 4, 2006 | Abandoned |
Array
(
[id] => 5422979
[patent_doc_number] => 20090149434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'FORMULATIONS WITH IMPROVED BIOAVAILABILITY, COMPRISING A STEROID DERIVATIVE AND A POLYGLYCOLYSED GLYCERIDE'
[patent_app_type] => utility
[patent_app_number] => 12/088060
[patent_app_country] => US
[patent_app_date] => 2006-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8192
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20090149434.pdf
[firstpage_image] =>[orig_patent_app_number] => 12088060
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/088060 | FORMULATIONS WITH IMPROVED BIOAVAILABILITY, COMPRISING A STEROID DERIVATIVE AND A POLYGLYCOLYSED GLYCERIDE | Sep 28, 2006 | Abandoned |
Array
(
[id] => 5193555
[patent_doc_number] => 20070082039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids, the use of the same as percutaneous permeation enhancers, and topical gels for the transdermal delivery of steroids'
[patent_app_type] => utility
[patent_app_number] => 11/527957
[patent_app_country] => US
[patent_app_date] => 2006-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10923
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20070082039.pdf
[firstpage_image] =>[orig_patent_app_number] => 11527957
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/527957 | Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids, the use of the same as percutaneous permeation enhancers, and topical gels for the transdermal delivery of steroids | Sep 26, 2006 | Abandoned |
Array
(
[id] => 5297244
[patent_doc_number] => 20090012170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'TREATMENT OF SYMPTOMS OF MOTOR DYSFUNCTION'
[patent_app_type] => utility
[patent_app_number] => 12/067070
[patent_app_country] => US
[patent_app_date] => 2006-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1790
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012170.pdf
[firstpage_image] =>[orig_patent_app_number] => 12067070
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/067070 | TREATMENT OF SYMPTOMS OF MOTOR DYSFUNCTION | Sep 19, 2006 | Abandoned |
Array
(
[id] => 5107750
[patent_doc_number] => 20070066628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => '5-Aryl-indan-1-ol and analogs useful as progesterone receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 11/522881
[patent_app_country] => US
[patent_app_date] => 2006-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19660
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0066/20070066628.pdf
[firstpage_image] =>[orig_patent_app_number] => 11522881
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/522881 | 5-Aryl-indan-1-ol and analogs useful as progesterone receptor modulators | Sep 17, 2006 | Abandoned |
Array
(
[id] => 5056460
[patent_doc_number] => 20070059382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Medical treatment of breast cancer with boric acid materials'
[patent_app_type] => utility
[patent_app_number] => 11/519116
[patent_app_country] => US
[patent_app_date] => 2006-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10400
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059382.pdf
[firstpage_image] =>[orig_patent_app_number] => 11519116
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/519116 | Medical treatment of breast cancer with boric acid materials | Sep 10, 2006 | Abandoned |
Array
(
[id] => 5417082
[patent_doc_number] => 20090042969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Use of Specific Trifluoromethyl Ketones for Preventing and Treating Pancreatitis'
[patent_app_type] => utility
[patent_app_number] => 11/990003
[patent_app_country] => US
[patent_app_date] => 2006-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4489
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20090042969.pdf
[firstpage_image] =>[orig_patent_app_number] => 11990003
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/990003 | Use of Specific Trifluoromethyl Ketones for Preventing and Treating Pancreatitis | Aug 8, 2006 | Abandoned |
Array
(
[id] => 4853349
[patent_doc_number] => 20080319092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Transdermal Drug Delivery Formulation'
[patent_app_type] => utility
[patent_app_number] => 12/063028
[patent_app_country] => US
[patent_app_date] => 2006-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13896
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0319/20080319092.pdf
[firstpage_image] =>[orig_patent_app_number] => 12063028
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/063028 | Transdermal Drug Delivery Formulation | Aug 3, 2006 | Abandoned |
Array
(
[id] => 4698889
[patent_doc_number] => 20080221073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'Nitrooxy Derivatives of Glucocorticoids'
[patent_app_type] => utility
[patent_app_number] => 12/065561
[patent_app_country] => US
[patent_app_date] => 2006-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10719
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221073.pdf
[firstpage_image] =>[orig_patent_app_number] => 12065561
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/065561 | Nitrooxy Derivatives of Glucocorticoids | Aug 3, 2006 | Abandoned |
Array
(
[id] => 4873773
[patent_doc_number] => 20080200507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Crystalline Non-Solvated Methanesulfonic Acid Salt of 1-(4-(2-Piperidinylethoxy)Phenoxy)-2-(3-Hydroxyphenyl)-6-Hydroxynaphthalene'
[patent_app_type] => utility
[patent_app_number] => 11/995852
[patent_app_country] => US
[patent_app_date] => 2006-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6494
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20080200507.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995852
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995852 | Crystalline Non-Solvated Methanesulfonic Acid Salt of 1-(4-(2-Piperidinylethoxy)Phenoxy)-2-(3-Hydroxyphenyl)-6-Hydroxynaphthalene | Jul 26, 2006 | Abandoned |
Array
(
[id] => 6228987
[patent_doc_number] => 20100183725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'MULTIPLE ACTIVE PHARMACEUTICAL INGREDIENTS COMBINED IN DISCRETE INHALATION PARTICLES AND FORMULATIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/988913
[patent_app_country] => US
[patent_app_date] => 2006-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6716
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20100183725.pdf
[firstpage_image] =>[orig_patent_app_number] => 11988913
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/988913 | MULTIPLE ACTIVE PHARMACEUTICAL INGREDIENTS COMBINED IN DISCRETE INHALATION PARTICLES AND FORMULATIONS THEREOF | Jul 16, 2006 | Abandoned |
Array
(
[id] => 5242906
[patent_doc_number] => 20070021401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Metal complexes of N-heterocyclic carbenes as radiopharmaceuticals and antibiotics'
[patent_app_type] => utility
[patent_app_number] => 11/482410
[patent_app_country] => US
[patent_app_date] => 2006-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14023
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021401.pdf
[firstpage_image] =>[orig_patent_app_number] => 11482410
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/482410 | Metal complexes of N-heterocyclic carbenes as antibiotics | Jul 6, 2006 | Issued |
Array
(
[id] => 4814026
[patent_doc_number] => 20080194657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Thiazole Derivatives for Treating Restless Legs Syndrome'
[patent_app_type] => utility
[patent_app_number] => 11/995089
[patent_app_country] => US
[patent_app_date] => 2006-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1383
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194657.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995089
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995089 | Thiazole Derivatives for Treating Restless Legs Syndrome | Jul 6, 2006 | Abandoned |
Array
(
[id] => 5436285
[patent_doc_number] => 20090170872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'Compounds and Their Pharmaceutical Use'
[patent_app_type] => utility
[patent_app_number] => 11/988303
[patent_app_country] => US
[patent_app_date] => 2006-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14229
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170872.pdf
[firstpage_image] =>[orig_patent_app_number] => 11988303
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/988303 | Compounds and Their Pharmaceutical Use | Jul 3, 2006 | Abandoned |
Array
(
[id] => 4839457
[patent_doc_number] => 20080279942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Pharmaceutical Preparation Containing an Angiotensin II Receptor Antagonist and a Calcium Channel Blocker'
[patent_app_type] => utility
[patent_app_number] => 11/922543
[patent_app_country] => US
[patent_app_date] => 2006-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6688
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20080279942.pdf
[firstpage_image] =>[orig_patent_app_number] => 11922543
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/922543 | Pharmaceutical Preparation Containing an Angiotensin II Receptor Antagonist and a Calcium Channel Blocker | Jun 25, 2006 | Abandoned |
Array
(
[id] => 4728180
[patent_doc_number] => 20080207724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Use of Inhibitors of Histone Deacteylases in Combination With Compounds Acting as Nsaid for the Therapy of Human Diseases'
[patent_app_type] => utility
[patent_app_number] => 11/995711
[patent_app_country] => US
[patent_app_date] => 2006-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10024
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207724.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995711
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995711 | Use of Inhibitors of Histone Deacteylases in Combination With Compounds Acting as Nsaid for the Therapy of Human Diseases | Jun 13, 2006 | Abandoned |
Array
(
[id] => 5687739
[patent_doc_number] => 20060286054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PSORIASIS'
[patent_app_type] => utility
[patent_app_number] => 11/420642
[patent_app_country] => US
[patent_app_date] => 2006-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9247
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286054.pdf
[firstpage_image] =>[orig_patent_app_number] => 11420642
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/420642 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PSORIASIS | May 25, 2006 | Abandoned |
Array
(
[id] => 4995158
[patent_doc_number] => 20070010503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Compounds useful for treating neurodegenerative disorders'
[patent_app_type] => utility
[patent_app_number] => 11/434726
[patent_app_country] => US
[patent_app_date] => 2006-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 19252
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20070010503.pdf
[firstpage_image] =>[orig_patent_app_number] => 11434726
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/434726 | Compounds useful for treating neurodegenerative disorders | May 15, 2006 | Issued |